ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: To further assess the possible clinical benefit of the combination strategy, we investigated the efficacy of the combination treatment in three patient-derived BCR–ABL+ CML samples obtained from diagnosis without prior treatment (patient information provided in Supplementary Table S2).